A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel® with CPG 7909, using two different formulations and dosing intervals
Titel:
A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel® with CPG 7909, using two different formulations and dosing intervals
Auteur:
Ellis, Ruth D. Mullen, Gregory E.D. Pierce, Mark Martin, Laura B. Miura, Kazutoyo Fay, Michael P. Long, Carole A. Shaffer, Donna Saul, Allan Miller, Louis H. Durbin, Anna P.